Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer

Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer

B7-H3 (CD276), a member of the family of immune modulators, orchestrates antitumor immunity. To date, only small-sized studies have examined the association of B7-H3 expression with survival in pancreatic cancer, yielding inconclusive results. We evaluated tumor B7-H3 expression in 150 consecutive p...

Full description

Bibliographic Details
Main Authors: Kentaro Inamura, Yutaka Takazawa, Yosuke Inoue, Yusuke Yokouchi, Maki Kobayashi, Akio Saiura, Tomoko Shibutani, Yuichi Ishikawa
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:Journal of Clinical Medicine
Subjects:
B7-H3
clinical outcome
immune checkpoint inhibitor
immune modulator
immunotherapy
pancreatic ductal adenocarcinoma
prognosis
tumor microenvironment
Online Access:http://www.mdpi.com/2077-0383/7/7/172

Internet

http://www.mdpi.com/2077-0383/7/7/172

Similar Items